Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow.
Mast cells derived from mouse bone marrow fail to demonstrate a disodium-cromoglycate-induced inhibition of mediator release when the cromolyn is added simultaneously with a secretagogue. To investigate the long-term effects of cromolyn exposure, cells from BALB/C femoral bone marrow stimulated with IL-3 were cultured in the presence of 1 to 100 microM cromolyn and demonstrated a similar viability and ability to proliferate as cells cultured in medium alone. Those cultured in cromolyn exhibited a significantly decreased A23187- or antigen-induced release of beta-hexosaminidase (4.3 +/- 0.7% versus 9.2 +/- 1.0%, p less than 0.01) compared with control cells. The adenosine-induced potentiation of mediator release was diminished to a comparable degree after cromolyn exposure in culture. This inhibition was dose-dependent between 1 and 100 microM cromolyn, evident by 5 days, reversible in 6 more days, and applied to immunoreactive leukotriene C4 generation as well. Bone marrow mast cells respond to chronic cromolyn exposure with a global inhibition of mediator release, but the basis for this response is unknown.
D000241:Adenosine / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D001854:Bone Marrow Cells; D004205:Cromolyn Sodium / Q000494:pharmacology*; D006596:Hexosaminidases / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D013189:SRS-A / Q000096:biosynthesis; D001619:beta-N-Acetylhexosaminidases
D013189:SRS-A; D000255:Adenosine Triphosphate; D006596:Hexosaminidases; D001619:beta-N-Acetylhexosaminidases; D000241:Adenosine; D004205:Cromolyn Sodium